Title |
Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)
|
---|---|
Published in |
Annals of Surgical Oncology, May 2014
|
DOI | 10.1245/s10434-014-3721-7 |
Pubmed ID | |
Authors |
Elizabeth L. Cureton, Christina Yau, Michael D. Alvarado, Helen Krontiras, David W. Ollila, Cheryl A. Ewing, Sindy Monnier, Laura J. Esserman |
Abstract |
Increasingly, women with stage 2 and 3 breast cancers receive neoadjuvant therapy, after which many are eligible for breast-conserving surgery (BCS). The question often arises as to whether BCS, if achievable, provides adequate local control. We report the results of local recurrence (LR) from the I-SPY 1 Trial in the setting of maximal multidisciplinary treatment where approximately 50 % of patients were treated with BCS. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 36 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 22% |
Student > Master | 5 | 14% |
Student > Bachelor | 4 | 11% |
Student > Postgraduate | 4 | 11% |
Other | 2 | 5% |
Other | 4 | 11% |
Unknown | 10 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 41% |
Computer Science | 3 | 8% |
Psychology | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Business, Management and Accounting | 1 | 3% |
Other | 3 | 8% |
Unknown | 11 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2014.
All research outputs
#18,371,959
of 22,755,127 outputs
Outputs from Annals of Surgical Oncology
#4,968
of 6,445 outputs
Outputs of similar age
#164,643
of 227,857 outputs
Outputs of similar age from Annals of Surgical Oncology
#54
of 88 outputs
Altmetric has tracked 22,755,127 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,445 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,857 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.